Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.6 HKD | +2.84% | +16.85% | -15.27% |
30/04 | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
29/04 | Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points | MT |
- Stock Market
- Equities
- 2162 Stock
- News Keymed Biosciences Inc.
- Analyst Reco.